• Listed Companies
  • Circulars
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Apr 25, 2024
    06:13

    Notification Letter to Non-registered Shareholders and Request Form

    Other

    00882 - TIANJIN DEV


  • Apr 25, 2024
    06:12

    Notification Letter to Existing Shareholders and Request Form

    Other

    00882 - TIANJIN DEV


  • Apr 25, 2024
    06:08

    General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors, Proposed Adoption of the New Articles of Association and Notice of Annual General Meeting

    Amendment of Constitutional Documents

    00882 - TIANJIN DEV


  • Dec 29, 2023
    17:22

    Reply Form - Election as to Means of Receipt of Corporate Communications

    Other

    00882 - TIANJIN DEV


  • Dec 29, 2023
    17:19

    First Letter - Election as to Means of Receipt of Corporate Communications

    Other

    00882 - TIANJIN DEV


  • Nov 09, 2023
    18:42

    Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary General Meeting

    Connected Transaction

    00882 - TIANJIN DEV


  • Apr 26, 2023
    18:34

    General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors and Notice of Annual General Meeting

    Re-election or Appointment of Director subject to Shareholders' Approval

    00882 - TIANJIN DEV


  • Nov 29, 2022
    19:09

    Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement and Notice of Extraordinary General Meeting

    Continuing Connected Transaction

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2025 All right reserved.